17q12 Knowledge Basedeletion syndrome · static snapshot
Adults Scientists Kids EN NL
All content was collected from public internet sources and processed with the help of AI/LLM software. This site is informative only — do not draw conclusions; verify with the original sources. Full disclaimer
Source updated How it is diagnosed 1 supporting source confidence 80% novelty 80%

Updated: Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns

pmc changed: +17/-42 sentences since the previous capture.

More source updated

How this was derived

Version 2 captured 2026-11-14. Newly added text includes: “1 Introduction Chromosomal microarray analysis (CMA) is a first‐tier diagnostic tool to identify chromosomal anomalies in patients with multiple congenital anomalies, unexplained developmental delay, intellectual disability, or autism spectrum disorder [ 1 ]. 2 Materials and Methods 2.1 Patients We retrospectively analyzed medical records of asymptomatic neonates referred to the Genetics Clinic at”

Generated 2026-11-14, last changed today. Dedup key update:208. The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.

Evidence (1 quote)

Clinical and Genetic Significance of Chromosomal Microarray Screening of Asymptomatic Newborns peer_reviewed · published 2026-11-14T01:32:56+00:00 · live page
1 Introduction Chromosomal microarray analysis (CMA) is a first‐tier diagnostic tool to identify chromosomal anomalies in patients with multiple congenital anomalies, unexplained developmental delay, intellectual disability, or autism spectrum disorder [ 1 ]. 2 Materials and Methods 2.1 Patients We retrospectively analyzed medical records of asymptomatic neonates referred to the Genetics Clinic at

Supporting documents (1)

DocumentSourcePublishedSeenRelevance
Clinical and Genetic Significance of Chromosomal Microarray Screeni... pmc 2026-01-01 yesterday 1.00